Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer

BJU International

Volumn 110, Issue 1, 2012, Pages 50-55

  Washington, Samuel L ^a   Bonham, Michael ^b   Whitson, Jared M ^a   Cowan, Janet E ^a   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Humans; Male; Prostatic neoplasms pathology; Prostatic neoplasms surgery

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER RISK; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; GLEASON SCORE; HUMAN; HUMAN TISSUE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME;

BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84862294237     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10704.x     Document Type: Article

References (26)

1. American Cancer Society. Cancer Facts & Figures 2010. Atlanta: American Cancer Society, 2010
2. Dall'Era MA, Konety BR, Cowan JE et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 2008; 112: 2664-70 (Pubitemid 351969209)
3. Davis JW, Kim J, Ward JF et al. Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extendedcore biopsies: an analysis of volume and zonal distribution of tumour foci. BJU Int 2010; 105: 1386-91
4. Ahmed HU, Emberton M. Benchmarks for success in focal therapy of prostate cancer: cure or control? World J Urol 2010; 28: 577-82
5. Eggener SE, Scardino PT, Carroll PR et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. Urology 2007; 178: 2260-7 (Pubitemid 350052204)
6. Klotz L. Active surveillance for prostate cancer: a review. Curr Urol Rep 2010; 11: 165-71
7. Ahmed HU. The Index Lesion and the origin of prostate cancer. N Engl J Med 2009; 361: 1704-6
8. Mullerad M, Hricak H, Kuroiwa K et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. Urology 2005; 174: 2158-63 (Pubitemid 41611764)
9. Kattan MW, Eastham JA, Stapleton AMF, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomyfor prostate cancer. J Natl Cancer Inst 1998; 90: 766-71 (Pubitemid 28259189)
10. D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74 (Pubitemid 28445094)
11. Schulte RT, Wood DP, Daignault S, Shah RB, Wei JT. Utility of extended pattern prostate biopsies for tumor localization. Cancer 2008; 113: 1559-65
12. Introini C, Naselli A, Vigliercio G, Spina B, Truini M, Puppo P. Can biopsy be a reliable predictor of spatial distribution fo prostate cancer' Comparison of a novel biopsy regimen with radical prostatectomy findings. Urology 2006; 68: 1301-4 (Pubitemid 44880350)
13. Louie-Johnsun M, Neill M, Treurnicht K, Jarmulowicz M, Eden C. Final outcomes of patients with low-risk prostate cancer suitable for active surveillance but treated surgically. BJU Int 2009; 104: 1501-4
14. Lattouf JB, Saad F. Gleason Score on biopsy: is it reliable for predicting the final grade on pathology? BJU Int 2002; 90: 694-9
15. Choo R, Danjoux C, Morton G et al. How much does Gleason Grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason Score 4-7, clinically localized prostate cancer? Prostate 2007; 67: 1614-20 (Pubitemid 350036947)
16. Sved PD, Gomez P, Manoharan M, Kim SS, Soloway MS. Limitations of biopsy gleason grade: implications for counseling patients with biopsy gleason score 6 prostate cancer. Urology 2004; 172: 98-102 (Pubitemid 41615047)
17. Antunes AA, Leite KR, Dall'Oglio MF, Cury J, Srougi M. The effect of the number of biopsy cores on the concordance between prostate biopsy and prostatectomy Gleason score: a prostate volume-controlled study. Arch Pathol Lab Med 2008; 132: 989-92 (Pubitemid 351918707)
18. Rubin MA, Mucci NR, Manley S et al. Predictors of Gleason Pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively? Urology 2001; 165: 114-8
19. Noguchi M, Stamey TA, McNeal JE, Yemoto CEM. Assessment of morphometric measurements of prostate carcinoma volume. C ancer 2000; 89: 1056-64
20. Obek C, Louis P, Civantos F, Soloway MS. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. Urology 1999; 161 (February): 494-9
21. Wefer AE, Hricak H, Vigneron DB et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000; 164: 400-4 (Pubitemid 30481935)
22. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71: (3 Suppl.): 933-8 (Pubitemid 23049614)
23. Karavitakis M, Winkler M, Abel P, Livni N, Beckley I, Ahmed HU. Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 2011; 14: 46-52
24. Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 2010; 106: 1607-11
25. Abouassaly R, Lane BR, Jones JS. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol. Urology 2008; 71: 573-7 (Pubitemid 351442978)
26. Altay B, KefiA, Nazli O, Killi R, Semerci B, Akar I. Comparison of Gleason Score from sextant prostate biopsies and radical prostatectomy specimens. Urol Int 2001; 67: 14-8 (Pubitemid 32679651)